Search - tctmd.com

Displaying 61 - 80 of 126

Sort: Relevancy | Date

Presentation THT Abstracts 2024

Real-world outcomes of patients implanted with a pulmonary artery pressure sensor: Insights from the HF2 Registry

Presenter: Elizabeth Volz

March 05, 2024

Presentation THT Abstracts 2024

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Presenter: Kevin John

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Presenter: Eduardo Arias

March 05, 2024

Presentation THT Abstracts 2024

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Presenter: Justin Cortez

March 05, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides

Presenter: Andrew Sauer

March 05, 2024

Presentation THT Abstracts 2024

Newly Developed Cardiogenic Shock Team: 10 month update

Presenter: Robin Miller

March 05, 2024

Presentation THT Abstracts 2024

Microtech Left Atrial Pressure Monitoring Submillimeter Sensor & System

Presenter: Yoram Richter

March 05, 2024

Presentation THT Abstracts 2024

Longitudinal Near-Infrared Spectroscopy Intravascular Ultrasound Assessment of Donor-transmitted Lipid Content and Plaque Volume in Coronary Arteries after Heart Transplantation

Presenter: Tatsuya Shiraki

March 05, 2024

Presentation THT Abstracts 2024

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Presenter: Daniel Bensimhon

March 05, 2024

Presentation THT Abstracts 2024

Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients

Presenter: Changhee Lee

March 05, 2024

Presentation THT Abstracts 2024

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Presenter: John Eisenga

March 05, 2024

Presentation THT Abstracts 2024

Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures

Presenter: Andrew Sauer

March 05, 2024

Presentation THT Abstracts 2024

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Presenter: Matteo Fabbri

March 05, 2024

Presentation THT Abstracts 2024

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Presenter: Boaz Elad

March 05, 2024

Presentation THT Abstracts 2024

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Presenter: Daniel Snyder

March 05, 2024

Presentation THT Abstracts 2024

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Presenter: Julia Baranowska

March 05, 2024

Presentation THT Abstracts 2024

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Presenter: Alexandra Steverson

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Presenter: Kevin John

March 05, 2024

Advertisement

Real-world outcomes of patients implanted with a pulmonary artery pressure sensor: Insights from the HF2 Registry

Predictors of Acute Limb Ischemia in Cardiogenic Shock patients on Mechanical Circulatory Support

Percutaneous VA-ECMO during TAVI in Patients with Cardiogenic Shock and Severely Depressed Left Ventricular Function

Percutaneous Axillary Intra-aortic Balloon Pumps for Cardiogenic Shock Due to Acute Decompensated Heart Failure as a Bridge to Ambulation and Heart Transplant

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Non-Invasive Multisensor Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptides

Newly Developed Cardiogenic Shock Team: 10 month update

Microtech Left Atrial Pressure Monitoring Submillimeter Sensor & System

Longitudinal Near-Infrared Spectroscopy Intravascular Ultrasound Assessment of Donor-transmitted Lipid Content and Plaque Volume in Coronary Arteries after Heart Transplantation

High Frequency Virtual Cardiology Intervention (HF-VCI) in implementing Heart Failure Guideline-Directed Medical Therapy (HF-GDMT)

Guideline-Directed Heart Failure Therapy in HeartMate 3 Patients

Glucagon-Like Peptide-1 Agonist Experience in Patients With Left Ventricular Assist Devices

Functional Outcomes Following Temporary Mechanical Circulatory Support Bridging to Left Ventricular Assist Device (LVAD)

Early feasibility study of a prototype device to non-invasively measure cardiac and pulmonary vascular pressures

Duration of Intra-Aortic Entrainment Pump Therapy and Clinical Outcomes in Acute Decompensated Heart Failure and Cardiorenal Syndrome

Durable Left Ventricular Assist Devices Improve Microcirculatory Health

Does Surgical or Catheter-Based Intervention Improve Outcomes for Patients with High-Risk Pulmonary Embolism on Veno-arterial Extracorporeal Membrane Oxygenation Compared to the Use of Anticoagulation Alone

Does Guideline-Directed Medical Therapy Improve Outcomes in HeartMate 3 Patients?

Disparities in Guideline Directed Medical Therapy (GDMT) Use and Dosing in Rural (versus Non-Rural) Veterans with Heart Failure with Reduced Ejection Fraction (HFrEF)

Clinical Outcomes and the Impact of SCAI Stage among ProtekDuo Right Ventricular Assist Device Recipients with Cardiogenic Shock: A Report from the Cardiogenic Shock Working Group

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content